by Jordana Choucair | May 3, 2022 | Opioid/Substance Use Disorders
Two Representatives sent a letter warning Attorney General Merrick Garland that the deals Teva Pharmaceuticals struck with Texas, Florida, and Rhode Island could create shortages of treatment and opioid reversal drugs in the rest of the country. “These...
by Jordana Choucair | Apr 28, 2022 | Opioid/Substance Use Disorders
Members of the House Oversight and Reform Committee questioned McKinsey & Company about its potential role in exacerbating the opioid epidemic. The hearing comes after the committee released a report alleging a years-long conflict of interest stemming from...
by Jordana Choucair | Apr 21, 2022 | Opioid/Substance Use Disorders
The White House is set to unveil President Joe Biden’s first National Drug Control Strategy today. The director of the White House Office of National Drug Control Policy, Dr. Rahul Gupta, said that the document prioritizes harm reduction, access to substance use...
by Jordana Choucair | Apr 20, 2022 | Opioid/Substance Use Disorders
Alabama reached a $276 million settlement with Johnson & Johnson, McKesson Corp., and Endo International PLC to resolve claims that they fueled the opioid crisis. The state attorney general said the money will go toward the state’s efforts to combat...
by Jordana Choucair | Apr 19, 2022 | Opioid/Substance Use Disorders
West Virginia announced it finalized a settlement with Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. over the drugmaker’s role in perpetuating the state’s opioid crisis. According to Attorney General Patrick Morrisey, the $99 million settlement is...
by Jordana Choucair | Apr 14, 2022 | Opioid/Substance Use Disorders
The Alliance for Addiction Payment Reform released a new brief that explores how utilizing coordinated and comprehensive medication management (CMM) in substance use disorder (SUD) treatment and recovery can enhance access to high quality care. CMM services for SUD...
Recent Comments